Literature DB >> 27770133

[Epidermal barrier disorders in dermatoses].

E Proksch1, D Dähnhardt2, R Fölster-Holst3.   

Abstract

The permeability barrier plays an important role in numerous skin diseases. Particularly well known is the importance of this barrier in eczema. In irritative-toxic contact dermatitis, the first step in the pathogenesis is the disturbance of the permeability barrier by irritative-toxic noxious substances. Only after damage to the barrier is achieved can irritants and allergens penetrate into the living epidermis. In atopic eczema due to an impaired barrier, allergens penetrate from the environment into the skin and cause or worsen the eczema. In psoriasis-the other common chronic inflammatory dermatosis-the role of the permeability barrier is only partly understood. In exanthema, infectious agents or drugs cause systemic inflammation, whereby the inflammation of the skin is followed by a barrier disorder. In principle, disturbed permeability of the skin barrier is present in all inflammatory diseases.

Entities:  

Keywords:  Eczema; Exanthema; Filaggrin; Permeability barrier; Psoriasis

Mesh:

Year:  2016        PMID: 27770133     DOI: 10.1007/s00105-016-3883-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  77 in total

1.  Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis.

Authors:  S Daehnhardt-Pfeiffer; C Surber; K-P Wilhelm; D Daehnhardt; G Springmann; M Boettcher; R Foelster-Holst
Journal:  Skin Pharmacol Physiol       Date:  2012-03-06       Impact factor: 3.479

2.  Filaggrin loss-of-function variant contributes to atopic dermatitis risk in the population of Northern Germany.

Authors:  A Ruether; M Stoll; T Schwarz; S Schreiber; R Fölster-Holst
Journal:  Br J Dermatol       Date:  2006-11       Impact factor: 9.302

3.  Topical treatment by urea reduces epidermal hyperproliferation and induces differentiation in psoriasis.

Authors:  I Hagemann; E Proksch
Journal:  Acta Derm Venereol       Date:  1996-09       Impact factor: 4.437

Review 4.  Epidermal barrier in hereditary ichthyoses, atopic dermatitis, and psoriasis.

Authors:  Matthias Schmuth; Stefan Blunder; Sandrine Dubrac; Robert Gruber; Verena Moosbrugger-Martinz
Journal:  J Dtsch Dermatol Ges       Date:  2015-11       Impact factor: 5.584

5.  Differential suppression of epidermal antimicrobial protein expression in atopic dermatitis and in EFAD mice by pimecrolimus compared to corticosteroids.

Authors:  Jens-Michael Jensen; Kerstin Ahrens; Josef Meingassner; Andreas Scherer; Matthias Bräutigam; Anton Stütz; Thomas Schwarz; Regina Fölster-Holst; Jürgen Harder; Regine Gläser; Ehrhardt Proksch
Journal:  Exp Dermatol       Date:  2011-06-24       Impact factor: 3.960

6.  Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum.

Authors:  Mariko Yokouchi; Akiharu Kubo; Hiroshi Kawasaki; Kazue Yoshida; Ken Ishii; Mikio Furuse; Masayuki Amagai
Journal:  J Dermatol Sci       Date:  2014-11-22       Impact factor: 4.563

7.  Basis for the permeability barrier abnormality in lamellar ichthyosis.

Authors:  Peter M Elias; Matthias Schmuth; Yoshikazu Uchida; Robert H Rice; Martin Behne; Debra Crumrine; Kenneth R Feingold; Walter M Holleran; D Pharm
Journal:  Exp Dermatol       Date:  2002-06       Impact factor: 3.960

8.  Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study.

Authors:  Hisako Enomoto; Kenji Hirata; Kenta Otsuka; Toshiharu Kawai; Takenori Takahashi; Tomomitsu Hirota; Yoichi Suzuki; Mayumi Tamari; Fujio Otsuka; Shigeharu Fujieda; Tadao Arinami; Emiko Noguchi
Journal:  J Hum Genet       Date:  2008-06-03       Impact factor: 3.172

9.  Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.

Authors:  Stephan Dähnhardt-Pfeiffer; Dorothee Dähnhardt; Matthias Buchner; Kersten Walter; Ehrhardt Proksch; Regina Fölster-Holst
Journal:  J Dtsch Dermatol Ges       Date:  2013-04-02       Impact factor: 5.584

10.  Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study.

Authors:  Regina Fölster-Holst; Jagoda Galecka; Sigo Weißmantel; Ute Dickschat; Frank Rippke; Kerstin Bohnsack; Thomas Werfel; Katja Wichmann; Matthias Buchner; Thomas Schwarz; Annika Vogt; Jürgen Lademann; Martina C Meinke
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-10-29
View more
  3 in total

Review 1.  [Neurodermatitis : Atopy of the skin].

Authors:  R Fölster-Holst
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

2.  Effects of Angelica gigas Nakai as an Anti-Inflammatory Agent in In Vitro and In Vivo Atopic Dermatitis Models.

Authors:  Seon Ok; Sa-Rang Oh; Tae-Sung Jung; Sang-Ok Jeon; Ji-Wook Jung; Deok-Seon Ryu
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-11       Impact factor: 2.629

3.  Evidence for the critical role of the PI3K signaling pathway in particulate matter-induced dysregulation of the inflammatory mediators COX-2/PGE2 and the associated epithelial barrier protein Filaggrin in the bronchial epithelium.

Authors:  Chenjian Song; Lingjing Liu; Junjie Chen; Yiran Hu; Jingli Li; Beibei Wang; Saverio Bellusci; Chengshui Chen; Nian Dong
Journal:  Cell Biol Toxicol       Date:  2019-12-28       Impact factor: 6.691

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.